Evidence map›Paper›PMID 31644429›Full record

ArticleAging2019

Mesenchymal stem cell senescence alleviates their intrinsic and seno-suppressive paracrine properties contributing to osteoarthritis development.

Olivier Malaise, Yassin Tachikart, Michael Constantinides, Marcus Mumme, Rosanna Ferreira-Lopez, Sandra Noack, Christian Krettek, Daniele Noël, Jing Wang, Christian Jorgensen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. DEL-1 is an Endogenous Senolytic Protein that Inhibits Senescence-Associated Bone Loss.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Olivier MalaiseIRMB, Univ Montpellier, INSERM, Montpellier, France.
Yassin TachikartIRMB, Univ Montpellier, INSERM, Montpellier, France.
Michael ConstantinidesIRMB, Univ Montpellier, INSERM, Montpellier, France.
Marcus MummeIRMB, Univ Montpellier, INSERM, Montpellier, France.
Rosanna Ferreira-LopezHôpital Lapeyronie, Clinical immunology and Osteoarticular Diseases Therapeutic Unit, Montpellier, France.
Sandra NoackTrauma Department, Hannover Medical School, Hannover, Germany.
Christian KrettekTrauma Department, Hannover Medical School, Hannover, Germany.
Daniele NoëlIRMB, Univ Montpellier, INSERM, Montpellier, France.
Jing WangINM, Univ Montpellier, INSERM, Montpellier, France.
Christian JorgensenIRMB, Univ Montpellier, INSERM, Montpellier, France.
Jean-Marc BrondelloIRMB, Univ Montpellier, INSERM, Montpellier, France.
Inserm · FRHôpital Lapeyronie · FRMedizinische Hochschule Hannover · DEUniversity Hospital of Basel · CHUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue accumulation of p16

Indexed as

AnimalsCell ProliferationCells, CulturedCellular SenescenceChondrocytesCoculture TechniquesCollagenasesEtoposideGene Expression RegulationHumansInflammationLuciferasesMaleMesenchymal Stem CellsMiceMice, Inbred StrainsCollagenasesEtoposideLuciferasesmesenchymal stem cellosteoarthritissenescencetissue homeostasis

Identifiers

PMID31644429
PMCPMC6834426
OpenAlexW2981715706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.